John Armitage Egerton Capital (UK)
John Armitage is the chief investment officer of Egerton Capital, a London-based long/short equity firm. Egerton is known for fundamental research and a portfolio of high-quality global companies, often with a growth-at-a-reasonable-price tilt. Institutional investors follow the firm for its long track record in developed-market equities.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDLN
Medline Inc
MDLN
|
+$488M |
| 2 |
Amazon
AMZN
|
+$304M |
| 3 |
Amphenol
APH
|
+$288M |
| 4 |
Equifax
EFX
|
+$252M |
| 5 |
Applied Materials
AMAT
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Carpenter Technology
CRS
|
+$525M |
| 2 |
Linde
LIN
|
+$389M |
| 3 |
CME Group
CME
|
+$349M |
| 4 |
Canadian Natural Resources
CNQ
|
+$277M |
| 5 |
Interactive Brokers
IBKR
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 28.95% |
| 2 | Technology | 20.15% |
| 3 | Materials | 11.66% |
| 4 | Communication Services | 11.24% |
| 5 | Consumer Discretionary | 8.23% |
Similar funds
John Armitage's Q2 2026 Portfolio in Review
As of Q2 2026, John Armitage held 29 positions worth $10.4B, up 15% from $9.01B the previous quarter. Its ten largest holdings account for 76% of the portfolio.
John Armitage deployed $326M of net new capital in Q2 2026, opening 5 new positions and adding to 13 existing holdings. Its largest new stake was Equifax: 1,481,188 shares worth $235M.
By sector, the portfolio is most concentrated in Financials at 29% of assets, down from 35% a quarter earlier, followed by Technology and Materials.
On the sell side, the largest reduction was Linde, an estimated $389M trimmed.
- John Armitage's largest Q2 2026 buy was Equifax: 1,481,188 shares worth $235M.
- John Armitage added most to Medline Inc in Q2 2026, an estimated $488M increase.
- John Armitage's biggest Q2 2026 reduction was Linde, cutting an estimated $389M.
- John Armitage fully exited Carpenter Technology in Q2 2026, selling an estimated $525M.
- John Armitage's ten largest holdings make up 76% of its $10.4B portfolio in Q2 2026.
- John Armitage opened 5 new positions and closed 6 in Q2 2026.
- John Armitage's portfolio value rose 15% quarter-over-quarter to $10.4B.
Based on Egerton Capital (UK)'s 13F filing for Q2 2026, filed 21 Jul 2026.